The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Over the past six months, Solventum’s stock price fell to $67.18. Shareholders have lost 6% of their capital, which is disappointing considering the S&P 500 has climbed by 2.6%. This may have ...

Business: Solventum, formerly known as 3M Health Care, is a global health-care company that was spun out from 3M on April 1. It has four main segments. First, there is Medical Surgical, a provider of ...

Solventum's main strategic priority is to repay debt following its separation from 3M. The business has consistently underperformed in its end markets, and a turnaround will take time. 3M appears to ...

The company guided to an organic sales growth range of 2% to 3% for 2026, translating to 3% to 4% excluding an estimated 100 basis point impact from SKU exits. Hanson stated that the Acera acquisition ...

Solventum, the recently spun off healthcare arm of 3M, faces challenges in value creation due to stagnant growth, heavy debt burden, and entanglement with its former parent. The company's revenue ...

Nelson Peltz’s Trian Partners sent a letter to the shareholders of Solventum (SOLV), saying the company trades at a discount to peers and 3M (MMM), Scott Wapner of CNBC reports. Trian believes the ...

Healthcare solutions provider Solventum (NYSE:SOLV) announced in Q4 CY2025, but sales fell by 3.7% year on year to $2.00 billion. Its GAAP profit of $0.36 per share was 37.3% below analysts’ consensus ...